• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Aging Cell. Feb 2010; 9(1): 54–63.
PMCID: PMC2814091

DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells

Abstract

Within 2–3 months of in vitro culture-expansion, mesenchymal stromal cells (MSC) undergo replicative senescence characterized by cell enlargement, loss of differentiation potential and ultimate growth arrest. In this study, we have analyzed DNA methylation changes upon long-term culture of MSC by using the HumanMethylation27 BeadChip microarray assessing 27 578 unique CpG sites. Furthermore, we have compared MSC from young and elderly donors. Overall, methylation patterns were maintained throughout both long-term culture and aging but highly significant differences were observed at specific CpG sites. Many of these differences were observed in homeobox genes and genes involved in cell differentiation. Methylation changes were verified by pyrosequencing after bisulfite conversion and compared to gene expression data. Notably, methylation changes in MSC were overlapping in long-term culture and aging in vivo. This supports the notion that replicative senescence and aging represent developmental processes that are regulated by specific epigenetic modifications.

Keywords: aging, DNA methylation, human mesenchymal stromal cells, long-term culture, pyrosequencing, senescence

Introduction

Mesenchymal stromal cells (MSC) are precursors for mesodermal cell lineages such as osteocytes, chondrocytes, and adipocytes. They can be isolated from various tissues by plastic adherent growth under specific culture conditions. MSC are heterogeneous, and reliable markers for the definition of the multipotent subset of ‘mesenchymal stem cells’ remain to be elucidated (Horwitz et al., 2005; Dominici et al., 2006; Wagner & Ho, 2007). Nevertheless, the ease of isolation and the possibility of culture expansion to very high cell numbers as well as the absence of critical side effects of MSC in clinical trials raise hopes for a variety of therapeutic applications (Wagner & Ho, 2007).

Mesenchymal stromal cells have a restricted lifespan in vitro such as any other somatic cell and can therefore only be expanded for a limited number of cell divisions before entering a senescent state and unequivocally stopping proliferation. This is accompanied by enlargement and morphologic changes referred to as ‘fried egg morphology’. Furthermore, many groups have shown that long-term culture of MSC impairs their differentiation potential (Banfi et al., 2000; Baxter et al., 2004; Bonab et al., 2006; Noer et al., 2007; Wagner et al., 2008). Therefore, the senescent state needs to be taken into account for quality control of MSC in cellular therapy.

The phenomenon of replicative senescence was first described in the 1960s by Leonard Hayflick (Hayflick, 1965) and since then a scientific discussion is ongoing whether the so-called ‘Hayflick limit’ resembles the aging process of the whole organism. We have recently demonstrated that replicative senescence induces reproducible gene expression changes in MSC (Wagner et al., 2008; Schallmoser et al., 2009). Interestingly, these changes closely resemble age-associated gene expression changes in adult stem and progenitor cells of young vs. elderly donors (Wagner et al., 2009). This overlap in differential gene expression indicates that long-term culture and aging might be regulated by similar mechanisms.

Two different basic principles are conceivable for cellular aging: (i) it might either be due to accumulation of damage that leads to cellular deterioration (Kirkwood & Austad, 2000) or (ii) it results from a cellular program that is regulated by a biological clock (de Magalhaes & Church, 2005; Prinzinger, 2005). Various molecular pathways have been shown to be relevant for the process of aging and senescence such as telomere shortening, DNA damage, accumulation of the cyclin-dependent kinase inhibitor p16INK4a and oxidative stress (Kiyono et al., 1998; O’Hare et al., 2001; Di Donna et al., 2003; Ho et al., 2005; Janzen et al., 2006). Furthermore, it has been proposed that epigenetic changes such as DNA methylation play a central role in senescence and aging (Wilson & Jones, 1983; Young & Smith, 2001; Nilsson et al., 2005; Chambers et al., 2007; Shibata et al., 2007; Suzuki et al., 2008).

DNA methylation is the best characterized epigenetic modification. CpG dinucleotides in the mammalian genomic DNA may be methylated at cytosine moieties. Upon replication the same methylation pattern is established on the newly synthesized DNA strand by DNA methyltransferase 1 (DNMT1). Thereby, epigenetic modifications are inherited to both daughter cells (Jaenisch & Bird, 2003). Methylation may impact gene transcription by direct interference with transcription factors or with methyl-CpG-binding proteins that modify histones and thereby inactivate the respective promoter region. Other authors have previously suggested that methylation levels gradually decrease upon long-term culture (Wilson & Jones, 1983; Nilsson et al., 2005). This study is based on the hypothesis that long-term culture and aging are associated with epigenetic modifications at specific CpG sites.

Results

Long-term culture of MSC

Mesenchymal stromal cells were isolated from bone marrow aspirates from young donors (21–50 years) or from bone marrow aspirates from elderly donors (53–85 years) upon hip fracture as previously described (Wagner et al., 2009). All cell preparations fulfilled the criteria of MSC such as typical growth morphology, immunophenotype and in vitro differentiation potential (Fig. S1) (Dominici et al., 2006; Wagner & Ho, 2007). Within 2–3 months of long-term culture the cells underwent replicative senescence accompanied by a decreased adipogenic differentiation potential and an increased propensity for osteogenic differentiation (Wagner et al., 2008) whereas no spontaneous differentiation was observed under nondifferentiation conditions even at later passages. The proliferation rate decreased gradually until the cells finally stopped to proliferate (Fig. S2A). These senecent passages were associated with expression of senescence-associated beta-galactosidase (SA-beta-gal) and increased p16 gene expression (Fig. S3).

Replicative senescence affects DNA methylation patterns

To determine effects of long-term culture on DNA methylation patterns we harvested MSC of early passages (2nd passage; P2) and late passages (P8–P15) from eight donors. Methylation status at 27 578 CpG sites was simultaneously analyzed using the HumanMethylation27 BeadChip microarray (Illumina). Scatter plot analysis of methylation in early vs. late passages revealed that DNA methylation remains overall constant upon MSC culture expansion (Fig. 1A). However, several CpGs showed a highly significant degree of differential methylation between early and late passage in all eight MSC samples. Only differential methylation of more than 20% was considered to be relevant and these CpGs were considered for further analysis. Twenty-nine CpGs were hypermethylated upon long-term culture whereas 55 CpGs were hypomethylated (Fig. 1C; Table S1). Hypermethylated CpGs were distributed in the promoter regions and within 23 nonredundant and functionally characterized genes including distal-less homeobox 5 (DLX5), runt-related transcription factor 3 (RUNX3), and chromosome 10 open reading frame 27 (C10orf27). Hypomethylated CpGs were localized in the promoter regions and within 43 protein-coding genes including cycline-dependent kinase inbibitor 2B (CDKN2B), bone morphogenic proteins 10 and 15 (BMP10/15), left-right determination (LEFTY1), and distinct CpG sites within the RUNX3 promoter. The function of all differentially methylated genes was further classified by Gene Ontology analysis. Hypermethylated genes were significantly over-represented in the functional categories cell-matrix adhesion, embryonic morphogenesis and development whereas hypomethylated genes were rather associated with epidermal differentiation (Table S2). There was only a moderate enrichment of methylation changes in specific chromosome regions: Three of the hypermethylated genes were located at chromosome band 10q22 (P = 0.0003) whereas four of the hypomethylated genes were enriched at chr21q22 (P = 0.0012). Overall, our results inevitably demonstrate that long-term culture induces reproducible and significant methylation changes at specific CpG sites and especially seem to affect genes involved in development.

Fig. 1
CpG methylation changes upon long-term culture and aging. DNA methylation at 27 578 different CpG sites was analyzed using the HumanMethylation27 BeadChip microarray. Scatter plots represent the mean methylation levels of mesenchymal stromal cells from ...

DNA methylation changes upon aging

To further elucidate methylation changes in MSC upon aging, we next analyzed methylation profiles in MSC that were taken from the second passage of young or elderly donors, respectively. Several CpG sites revealed age-associated methylation changes (Fig. 1B). Two hundred and ninety-five CpGs were hypermethylated, whereas 349 CpGs were hypomethylated upon aging (Fig. 1D; Table S3). Genes associated with CpGs that were hypermethylated upon aging included HOXA2, HOXA5, HOXA6, HOXB2, DLX5, aristaless-like homeobox 4 (ALX4), T-box 5 isoform 2 (TBX5), RUNX2, RUNX3, O-6-methylguanin-DNA methyltransferase (MGMT) and C10orf27. Genes associated with CpGs that were hypomethylated upon aging included HOXB1, HOXB3, HOXB4, HOXB6, HOXD3, HOXD12, paired-like homeodomain transcription factors PITX1 and PITX2, sirtuin 6, BMP4, mesoderm specific transcript (MEST), paired box genes PAX1, PAX8, PAX9, TBX1, S100A4, and also RUNX3 and ALX4. Differentially methylated genes were further classified by Gene Ontology analysis. Hypermethylated genes were significantly over-represented in various signal transduction pathways and limb morphogenesis. In contrast to this, hypomethylated genes were most significantly over-represented in genes involved in sequence-specific DNA binding and developmental processes (Table S4). Furthermore, there was an enrichment of hypermethylated genes at the chromosome regions chr21q22 (9 genes; P = 0.0006), chr2p25 (5 genes; P = 0.0011), chr6q27 (4 genes; P = 0.0013), and chr12q24 (7 genes; P = 0.0073). Hypomethylated genes upon aging were enriched at chr20q13 (9 genes; P = 0.0032). Interestingly, methylation changes were highly enriched in genes with simian-virus-40-protein 1 (SP1) binding sites (hypermethylation: 15 of 258 genes, P = 7.8 × 10−11 and hypomethylation: 31 of 273 genes, P = 6.0 × 10−5).

Validation of differentially methylated genes by pyrosequencing

Differential methylation of six selected CpG sites (DLX5, HOXA5, S100A4, C10orf27, RUNX3, and CDKN2B) was validated by pyrosequencing after bisulfite conversion. Candidate genes were selected based on the correlation between gene expression and CpG island methylation as well as their attributed biological function. Methylation levels were overall slightly lower in pyrosequencing results as compared with microarray analysis. However, differential methylation upon long-term culture or upon aging was very consistent between the two methods (Fig. 2A,B). Moreover, differential methylation was also verified in three additional independent donor samples (Fig. S4A). Comparative analysis of different passages revealed that methylation changes are continuously acquired with every passage upon long-term culture (Fig. S4B). Notably, also CpGs in close neighborhood to the CpG represented on the microarray revealed very similar methylation patterns (Fig. 2C,D; Fig. S4C,D). This demonstrates that methylation changes are not restricted to individual CpG sites but rather affect whole CpG islands.

Fig. 2
Pyrosequencing of differentially methylated CpGs. For six CpG sites differential methylation of the HumanMethylation27 BeadChip (open circles) was validated by pyrosequencing (filled circles) (all 16 samples, ± SEM). Overall, methylation levels ...

Association of methylation changes in long-term culture and aging

We have previously shown that long-term culture and aging have similar effects on the gene expression profile of MSC (Wagner et al., 2008, 2009). Therefore, we hypothesized that these two processes might also reveal an association in DNA methylation changes. Only 13 CpGs were more than 20% differentially methylated in both comparisons and therefore we have chosen a less stringent cutoff of 15% differential methylation resulting in 80 CpGs (Fig. 3). These demonstrated a correlation in long-term culture and aging (R = 0.61) and chi-square analysis revealed a statistical significance of 4.6 × 10−9. Hence, it might be speculated that senescence-associated changes are more pronounced in samples from younger donors. Indeed, the number of more than 20% differentially methylated CpG sites upon long-term culture was 24% higher in younger vs. elderly donors (248 CpG sites vs. 189 CpG sites). These data indicate that long-term culture and aging resemble two processes with related epigenetic modifications.

Fig. 3
Comparison of differential methylation upon long-term culture and aging. Methylation changes upon long-term culture were plotted against methylation changes upon aging. CpGs with a more than 15% differential methylation in both comparisons are depicted ...

Association of DNA methylation and gene expression

DNA methylation profiles were integrated with gene expression data to determine the impact of epigenetic modifications on mRNA expression. For each CpG on the HumanMethylation27 BeadChip the corresponding gene was matched to the Affymetrix mRNA gene expression data by gene symbols (Wagner et al., 2009). Signal intensity in gene expression data was used as an indicator for gene expression levels. As expected, nonmethylated genes revealed higher gene expression levels than methylated genes (Fig. 4A). Subsequently, we tested if differential methylation was also reflected in differential gene expression. Overall the two microarray platforms did not reveal a clear correlation between differential CpG methylation and differential mRNA expression in long-term culture or aging (Fig. 4B,C). This might be due to the different sensitivity of the two techniques: 20% differential methylation can be detected, whereas 20% differential gene expression can not be reliably discerned. We have selectively addressed gene expression changes in genes that have been analyzed by pyrosequencing and that revealed higher methylation changes. mRNA expression of these genes (DLX5, HOXA5, CDKN2B, S100A4, RUNX3, and C10orf27) was analyzed by quantitative RT-PCR. For these selected genes hypermethylation coincided with lower gene expression and vice versa (Fig. 4D,E).

Fig. 4
Correlation of DNA methylation and gene expression. DNA methylation data of the HumanMethylation27 BeadChip was matched with Affymetrix mRNA expression profiles. As expected, signal intensity in gene expression data revealed higher expression of nonmethylated ...

Discussion

Epigenetic modifications play a central role in differentiation and development. This study indicates that modification of DNA methylation is also involved in replicative senescence upon long-term culture of MSC. Furthermore, a similar pattern of differential methylation was observed between MSC from young and elderly donors. These results support the perception that replicative senescence and aging are not only due to stochastic accumulation of cellular defects but rather represent a developmental program. On the other hand, the process is overlaid by stress-induced senescence changes e.g. due to high oxygen content or the artificial environment. Furthermore, the cellular aging of MSC might be accompanied by a different composition of heterogeneous subpopulations and loss of self-renewal potential under in vitro conditions. Hence, senescence of MSC has many facets that need to be further elucidated (Wagner et al., review submitted).

Methylation was analyzed by using the novel HumanMethylation27 BeadChip representing 27 578 CpGs that are associated with promoter regions of more than 13 500 annotated genes. This array was designed to cover CpG dinucleotides in the promoter region of genes and therefore is clearly biased toward the assessment of gene-specific methylation. Differential CpG methylation was highly reproducible in different donor samples and was verified by pyrosequencing for all sequences tested. Thus, this technique facilitates reliable profiling of global methylation patterns.

Other authors have reported that global DNA methylation levels decrease upon long-term culture (Wilson & Jones, 1983; Young & Smith, 2001). Therefore, it has been speculated that maintenance of DNA methylation by DNA methyltransferase 1 (DNMT1) is incomplete resulting in a gradual decrease of DNA methylation with repeated cell cycles (Nilsson et al., 2005). However, our results did not reveal an overall decrease in DNA methylation levels. In fact, methylation remained constant over the whole culture period at most CpG sites represented on the BeadChip. To our knowledge this study demonstrates for the first time that only specific CpG islands become differentially methylated upon long-term culture. DNA methylation changes upon aging may also depend on individual differences although differential methylation was verified by pyrosequencing in independent donor samples. It is also likely, that age-related changes are influenced by the different cellular composition upon aging as well as by the different tissue and isolation technique.

Methylation changes in our study were often associated with homeobox genes. Expression of these genes is tightly regulated under temporal control during vertebrate development. It has been shown that chromatin modifications play an important role for regulation of the ‘Hox clock’ that coordinates body patterning (Illingworth et al., 2008; Soshnikova & Duboule, 2009). Furthermore, age-associated gene expression changes have been described in homeobox genes (Stelnicki et al., 1998; Wagner et al., 2009) and it is conceivable that they are involved in the timing of aging. Exemplarily, we have verified differential methylation for HOXA5 and DLX5 upon long-term culture and aging by pyrosequencing. The homeobox gene DLX5 is also involved in differentiation toward the osteoblastic lineage (Lee et al., 2005). Therefore, hypermethylation and decreased gene expression of DLX5 might be relevant for the impaired differentiation capacity of MSC upon long-term culture. It has been shown that methylation changes at specific CpG sites can affect differentiation of MSC (Noer et al., 2007; Zimmermann et al., 2008). In addition, age-related methylation changes have been described. Several tumor suppressor genes are hypermethylated upon aging with potential implications for cancer susceptibility in the elderly (So et al., 2006). Among these was RUNX3 that revealed age-associated changes in our analysis. Another differentially methylated gene was the cycline-dependent kinase inbibitor 2B (CDKN2B) that has been implicated in senescence in our previous work (Schallmoser et al., 2009).

Several genes such as RUNX3 and ALX4 were more than 20% hypermethylated at specific CpG sites and more than 20% hypomethylated in others. These antagonistic modifications within the same promoter region indicate that DNA modifications are restricted to relatively short and specific sequences. On the other hand, pyrosequencing revealed that methylation changes are not restricted to unique CpG sites but also include neighboring cytidines of the same CpG island. It has been suggested that senescence can also be induced in immortal cells by treatment with 5aza-2deoxycytidine (5AZA) (Vogt et al., 1998). However, it is difficult to discern toxic effects of 5AZA. The complex pattern of hypermethylation and hypomethylation observed in this study might explain why replicative senescence cannot be controlled by demethylating agents.

De novo methylation is facilitated by DNA methyltransferases DNMT3A and DNMT3B but it is mostly unknown how the extent of de novo methylation is regulated and where it takes place. Active DNA hypomethylation is also considered to occur but a specific enzyme that removes the methyl group from 5-methylcytosine has not yet been described. It has been suggested that DNA methyltransferases exhibit dual actions in CpG methylation and demethylation of 5mCpGs through deamination (Kangaspeska et al., 2008; Metivier et al., 2008). DNA methylation patterns may vary drastically within CpG islands and only methylation of a defined core-region silences gene expression (Gonzalgo et al., 1998; Deng et al., 1999; Ushijima & Okochi-Takada, 2005). We have shown that age-associated hypermethylated and hypomethylated genes are enriched in SP1 transcription factor binding sites and it has been proposed that binding of the SP1 transcription factor protects CpG islands from methylation (Brandeis et al., 1994; Macleod et al., 1994). ‘Seeds of methylation’ is another interesting mechanism that leads to increasing methylation of CpG islands. This hypothesis is based on the observation that little methylation is induced in an initially nonmethylated region whereas a high degree of methylation is induced in a sparsely methylated region (Song et al., 2002; Stirzaker et al., 2004). This mechanism might serve as a cell-cycle counter.

It is commonly accepted that DNA methylation silences gene expression. This is also reflected by the correlation of the two different levels investigated in our study: nonmethylated genes revealed higher signal intensity in mRNA expression profiling. However, differential DNA methylation at specific CpG sites does not necessarily correlate with observed gene expression changes. Relevant fold-changes in gene expression can only be expected if the CpG sites are predominantly methylated. It is also conceivable that selective modification of specific promoter regions either activates or inactivates binding of transcription regulators.

We have previously described age-related gene expression changes in human stem and progenitor cells and observed a moderate but significant concordance in the expression profiles upon aging in vivo and replicative senescence in vitro (Wagner et al., 2009). However, the proliferation rate was not higher in MSC from younger donors and they did not reach a higher number of cumulative population doublings. This might be attributed to the relatively low number of samples per group as other authors reported an inverse relationship between donor age and the replicative life span in vitro for fibroblasts or MSC (Schneider & Mitsui, 1976; Stenderup et al., 2003; Mareschi et al., 2006; Shibata et al., 2007). Also the doubling time of either freshly isolated marrow cells or MSC of early passage has been described to be significantly lower in samples from elderly people (Zhou et al., 2008) whereas this was not observed in our study. Analysis of age-specific changes might be affected by the different sources for MSC that were available for the two age groups. MSC were either isolated from human bone marrow from the iliac crest or from the femoral head. There were no differences in growth, cell morphology, immunophenotype or differentiation potential (Wagner et al., 2009). Thus, MSC from BM and HIP fulfilled the criteria that are commonly used for definition of MSC although these cell preparations are heterogeneous and may comprise different subpopulations (Dominici et al., 2006; Wagner & Ho, 2007). However, we can not exclude that some of the methylation changes are due to the different bone marrow regions. Notably, however, there was a relevant overlap of methylation changes upon long-term culture and aging of MSC. Furthermore, there is a significant concordance of our age-related changes in MSC and age-associated methylation changes in ovarian cancer samples (Teschendorff et al., manuscript in preparation). Further integrative analysis of methylation profiles of different cell types and tissues will help to discern the existence of a distinct methylation signature for aging.

Bone marrow is a complex tissue with various different cell types. Hence, it is apparent that aging and replicative senescence are not identical despite molecular similarities of the two processes. Long-term culture has been shown to impair differentiation potential of MSC, especially of adipogenic differentiation (Baxter et al., 2004; Bonab et al., 2006; Wagner et al., 2008). By contrast, other authors demonstrated that aging activates adipogenic differentiation and suppresses osteogenic differentiation (Moerman et al., 2004; Zhou et al., 2008). These authors also demonstrated that expression of the master transcription factor for osteoblast differentiation RUNX2 and DLX5 decreased upon aging and this is in line with higher methylation as observed in our data. It is conceivable, that the higher propensity for adipogenesis in BM of elderly people results in a lower number of osteogenic progenitor cells.

Aging is not an inevitable fate of all cells. Our germ line cells and their progeny are sustained through the generations and embryonic stem cells as well as induced pluripotent stem cells do not show signs of replicative senescence upon long-term culture (Zeng, 2007). It is therefore conceivable, that the loss of pluripotency is directly accompanied with limitation of the replicative live span (Marciniak-Czochra et al., 2009). Both mechanisms might be regulated by similar epigenetic modifications that govern differentiation and development. Our results demonstrate that specific CpG sites become either methylated or demethylated upon long-term culture. Analysis of these specific CpG sites might facilitate monitoring of the replicative lifespan of cells. It will be of central interest to further increase our understanding of the mechanisms regulating senescence-associated and age-associated epigenetic modifications.

Experimental procedures

Isolation of MSC from human bone marrow

Mesenchymal stromal cells were isolated from human bone marrow that was either taken from aspirates from healthy donors for allogeneic transplantation (BM) or from the caput femoris from elderly patients undergoing femoral head prosthesis (HIP) as described in our previous work (Wagner et al., 2009). All samples were taken after written consent using guidelines approved by the Ethic Committee on the Use of Human Subjects at the University of Heidelberg. The standardized culture conditions have been described in detail before (Reyes et al., 2001; Wagner et al., 2005).

Expansion and sampling of MSC

Mesenchymal stromal cells were cultured for 2–3 month by serial passaging until the cells reached a senescent state and stopped proliferation. Culture conditions and sampling have been described in our previous work (Wagner et al., 2008, 2009). In brief, 7–10 days after the initial seeding of MNC the colonies were trypsinized and re-plated in a new culture flask (passage 1, P1). Upon sub-confluent growth (70%), cells were re-plated at a density of 104cells cm−2. Cells were counted at every passage by a Neubauer counting chamber and the cumulative population doublings were calculated (Cristofalo et al., 1998). As cell numbers were first determined at P1, the cumulative doubling number was first calculated for P2. From P2 onward, there were enough cells for simultaneous expansion of one fraction and harvesting another fraction for subsequent analyses: 106 cells were lysed in TRIzol for RNA isolation, 106 cells were cryopreserved for immunophenotyping and in vitro differentiation assays (Wagner et al., 2008, 2009) and 106 cells were pelleted and stored by −80 °C for subsequent DNA isolation.

Immunophenotypic analysis of MSC and in vitro differentiation of MSC

Immunophenotypic characterization of MSC preparations was performed on a three-color FACScan (Becton Dickinson [BD], San Jose, CA, USA) with a five-color upgrade (Cytek Dev. Inc., Fremont, CA, USA) using the commonly used panel of antibodies as described before (Wagner et al., 2009): CD13-allophycocyanin (APC, clone WM15, BD), CD29-fluorescein isothiocyanate (FITC, MEM-101a, abcam, Cambridge, UK), CD31-FITC (BD), CD34-phycoerythrin (PE, 8G12, BD), CD44-PE (g44-26, BD), CD45-FITC (2D1, BD), CD73-PE (AD2, BD), CD90-PE (G7, BD), CD105-PE (MHCD10504, BD), CD146-PE (P1H12, BD), CD166-PE (3A6, BD), CD184-PE (12G5, BD). Osteogenic and adipogenic differentiation of MSC was induced as previously described (Wagner et al., 2009). After 21 days osteogenic differentiation was analyzed by Alizarin red staining and adipogenic differentiation by Oil Red-O staining.

Senescence-associated beta-galactosidase staining

Expression of pH-dependent senescence-associated beta-galactosidase (SA-beta-gal) activity was analyzed simultaneously in different passages of MSC of young and elderly donors using the SA-beta-gal staining kit (Cell Signaling Technology, Boston, MA, USA).

DNA isolation and bisulfite conversion

Genomic DNA of 106 MSC was isolated using the QIAGEN DNA Blood Midi-Kit. DNA quality was assessed with a NanoDrop ND-1000 spectrometer (NanoDrop Technologies, Wilmigton, DE, USA) and average fragment length was assessed by gel electrophoresis. Genomic DNA (500 ng) from each sample was bisulfite converted using the EZ-96 DNA Methylation Kit (Zymo research Corporation, Orange, CA, USA). This step leads to the deamination of nonmethylated cytosines to uracils, while methylated cytosines are refractory to the effects of bisulfite and remain cytosine. After bisulfate conversion each sample was whole genome amplified and enzymatically fragmented.

Profiling of CpG methylation

The HumanMethylation27 BeadChip (Illumina, San Diego, CA, USA) uses Infinium technology, previously described for SNP genotyping (Steemers et al., 2006), to perform genome-wide screening of DNA methylation patterns. In detail, the HumanMethylation27 panel targets 27 578 unique CpG sites located within the proximal promoter regions of transcription start sites of 14 475 consensus coding sequencing (CCDS) in the NCBI Database (Genome Build 36). In addition, 254 assays cover 110 miRNA promoters. On average, two assays were selected per CCDS gene and from 3 to 20 CpG sites for >200 cancer-related and imprinted genes. Further specifications of the platform can be found at http://www.illumina.com/products/infinium_humanmethylation27_beadchip_kits.ilmn. About 200 ng DNA was applied per BeadChip according to the manufacturer’s instructions. During hybridization, the DNA molecules anneal to two different bead types with locus-specific DNA oligomers – one corresponds to the methylated (C) and the other to the unmethylated (T) state. Allele-specific primer annealing is followed by single-base extension using DNP- and Biotin-labeled ddNTPs. After extension, the array is fluorescently stained, scanned, and the intensities of the unmethylated and methylated bead types measured. Initial data analysis was performed with the BeadStudio Methylation Module. DNA methylation values, described as beta values, are recorded for each locus in each sample. Only few CpG sites did not reveal reliable signals, as determined by their detection P-value, and were therefore excluded from further analysis. Raw data were quantile normalized. Statistical analysis and clustering by Euclidian distance was performed using the MultiExperiment Viewer (MeV, TM4) (Saeed et al., 2003). For further analysis we have selected CpG sites with more than 20% differential methylation. These were further analyzed to calculate mean methylation, differential methylation and student’s t-test. Furthermore, genes associated to the differentially methylated CpG sites were categorized by Gene Ontology analysis using GoMiner software (http://discover.nci.nih.gov/gominer/). Chromosomal distribution and transcription factor binding was assessed by Gene Set Enrichment Analysis (Subramanian et al., 2005). The complete CpG methylation values have been deposited in NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible through GEO Series accession number GSE17448.

Pyrosequencing

Methylation changes of six selected CpG sites were validated by pyrosequencing. Independent bisulfite treatment and pyrosequencing assays were performed by Varionostic GmbH (Ulm, Germany). In brief, bisulfite converted DNA was subjected to PCR amplification. Primers are provided in Table S5. 40–45 μL of PCR product was immobilized to 3 μL Streptavidin SepharoseTM HP beads (GE Healthcare, Piscataway, NJ, USA) followed by annealing to 2 μL sequencing primer (5 μM) for 2′ at 80 °C. CpG analysis was done with Pyro Q-CpG software, and differential methylation was calculated as described above.

Gene expression profiling

In this study we have combined DNA methylation data with gene expression profiles of our previous work (Wagner et al., 2008, 2009). Gene expression profiles have been analyzed by the U133_Plus_2.0 Affymetrix chip and two different data sets were used for this comparison.

  1. MSC-replicative senescence (Wagner et al., 2008): MSC of three different donors were analyzed at passage 2 (P2) and at the senescent passage (Px). This resulted in a set of six hybridizations. Raw data were quantile normalized and log2 ratios were calculated vs. P2 of the corresponding donor sample. The complete microarray data are accessible through GEO Series accession number GSE9593.
  2. MSC-donor age (Wagner et al., 2009): MSC of four younger donors (21–50 years) and four elderly donors (53-85 years) were harvested at the second passage. These are the same donor samples that have also been used for methylation profiling. Raw data were quantile normalized and log2 ratios were calculated between the different age groups. The complete microarray data are accessible through GEO Series accession number GSE12274.

Gene expression data was matched to HumanMethylation27 BeadChip by gene symbols (HUGO names). For comparative analysis we have only considered probe sets that were detected as present in more than 50% of the hybridizations in gene expression analysis.

Quantitative real-time PCR analysis

Quantification of mRNA expression for candidate genes was performed by real-time quantitative PCR (QRT-PCR) using the ABI PRISM® 7700HT Sequence Detection System Instrument (Applied Biosystems, Applera Deutschland GmbH, Darmstadt, Germany). Total RNA was isolated and reverse transcribed as described in our previous work (Wagner et al., 2009). Primers were obtained from Biospring (Frankfurt, Germany) (Table S5). QRT-PCR reactions were performed with the power SYBR® green PCR master mix in a MicroAmp optical 96-well reaction plate with a ABI PRISM® 7700HT sequence detector (Applied Biosystems) according to the manufacturer’s instructions. Gene expression levels were normalized to GAPDH expression, which was used as a housekeeping gene.

Acknowledgments

We want to thank Anke Diehlmann (Department of Medicine V, Heidelberg, Germany) for assistance in MSC expansion, Juliane Rieber (DKFZ, Heidelberg, Germany) for help with DNA isolation, Roger Fischer (DKFZ, Heidelberg, Germany) for excellent technical assistance in bisulfite treatment and array analysis, and Dr. Uwe Gerstenmaier (Varionostic GmbH, Ulm, Germany) for support on pyrosequencing. This work was supported by the German Ministry of Education and Research (BMBF) within the supporting program ‘cell based regenerative medicine’ (START-MSC and CB-HERMES), the German Research Foundation DFG (HO 914/7-1), the Network for Aging Research (NAR, Heidelberg), the Heidelberg Academy of Sciences (WIN-Kolleg) and the Stem Cell Network North Rhine Westphalia.

Supporting Information

Additional supporting information may be found in the online version of this article:

Fig. S1 Immunophenotype and in vitro differentiation of mesenchymal stromal cells.

Fig. S2 Long-term culture of mesenchymal stromal cells.

Fig. S3 β-galactosidase staining and expression of p16 in early and late mesenchymal stromal cell passages.

Fig. S4 Methylation changes in independent donor samples and during long-term culture.

Table S1 Differentially methylated CpGs upon long-term culture.

Table S2 Gene ontology analysis of methylation changes in long-term culture.

Table S3 Differentially methylated CpGs upon aging.

Table S4 Gene ontology analysis of methylation changes upon aging.

Table S5 Primer sequences.

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer-reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

References

  • Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp. Hematol. 2000;28:707–715. [PubMed]
  • Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675–682. [PubMed]
  • Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;7:14. [PMC free article] [PubMed]
  • Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature. 1994;371:435–438. [PubMed]
  • Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 2007;5:201. [PMC free article] [PubMed]
  • Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc. Natl Acad. Sci. U.S.A. 1998;95:10614–10619. [PMC free article] [PubMed]
  • Deng G, Chen A, Hong J, Chae HS, Kim YS. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 1999;59:2029–2033. [PubMed]
  • Di Donna S, Mamchaoui K, Cooper RN, Seigneurin-Venin S, Tremblay J, Butler-Browne GS, Mouly V. Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol. Cancer Res. 2003;1:643–653. [PubMed]
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317. [PubMed]
  • Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT, Jones PA. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res. 1998;58:1245–1252. [PubMed]
  • Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 1965;37:614–636. [PubMed]
  • Ho AD, Wagner W, Mahlknecht U. Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine. EMBO Rep. 2005;6:35–38. [PMC free article] [PubMed]
  • Horwitz EM, Le BK, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–395. [PubMed]
  • Illingworth R, Kerr A, Desousa D, Jorgensen H, Ellis P, Stalker J, Jackson D, Clee C, Plumb R, Rogers J, Humphray S, Cox T, Langford C, Bird A. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 2008;6:e22. [PMC free article] [PubMed]
  • Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003;33(Suppl):245–254. [PubMed]
  • Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, Dombkowski DM, Cheng T, DePinho RA, Sharpless NE, Scadden DT. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006;443:421–426. [PubMed]
  • Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, Benes V, Gannon F, Reid G. Transient cyclical methylation of promoter DNA. Nature. 2008;452:112–115. [PubMed]
  • Kirkwood TB, Austad SN. Why do we age? Nature. 2000;408:233–238. [PubMed]
  • Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 1998;396:84–88. [PubMed]
  • Lee MH, Kim YJ, Yoon WJ, Kim JI, Kim BG, Hwang YS, Wozney JM, Chi XZ, Bae SC, Choi KY, Cho JY, Choi JY, Ryoo HM. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J. Biol. Chem. 2005;280:35579–35587. [PubMed]
  • Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 1994;8:2282–2292. [PubMed]
  • de Magalhaes JP, Church GM. Genomes optimize reproduction: aging as a consequence of the developmental program. Physiology (Bethesda) 2005;20:252–259. [PubMed]
  • Marciniak-Czochra A, Stiehl T, Wagner W. Modeling of replicative senescence in hematopoietic development. Aging. 2009;1:723–732. [PMC free article] [PubMed]
  • Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, Madon E, Fagioli F. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J. Cell. Biochem. 2006;97:744–754. [PubMed]
  • Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, Benes V, Jeltsch A, Gannon F, Salbert G. Cyclical DNA methylation of a transcriptionally active promoter. Nature. 2008;452:45–50. [PubMed]
  • Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell. 2004;3:379–389. [PMC free article] [PubMed]
  • Nilsson O, Mitchum RD, Jr, Schrier L, Ferns SP, Barnes KM, Troendle JF, Baron J. Growth plate senescence is associated with loss of DNA methylation. J. Endocrinol. 2005;186:241–249. [PubMed]
  • Noer A, Boquest AC, Collas P. Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol. 2007;8:18. [PMC free article] [PubMed]
  • O’Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, Berry C, Moody J, Silver AR, Davies DC, Alsop AE, Neville AM, Jat PS. Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc. Natl Acad. Sci. U.S.A. 2001;98:646–651. [PMC free article] [PubMed]
  • Prinzinger R. Programmed ageing: the theory of maximal metabolic scope. How does the biological clock tick? EMBO Rep. 2005;6:S14–S19. [PMC free article] [PubMed]
  • Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615–2625. [PubMed]
  • Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. BioTechniques. 2003;34:374–378. [PubMed]
  • Schallmoser K, Bartmann C, Rohde E, Bork S, Guelly C, Obenauf AC, Reinisch A, Horn P, Ho AD, Strunk D, Wagner W. Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica. 2009 (in press) [PMC free article] [PubMed]
  • Schneider EL, Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl Acad. Sci. U.S.A. 1976;73:3584–3588. [PMC free article] [PubMed]
  • Shibata KR, Aoyama T, Shima Y, Fukiage K, Otsuka S, Furu M, Kohno Y, Ito K, Fujibayashi S, Neo M, Nakayama T, Nakamura T, Toguchida J. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells. 2007;25:2371–2382. [PubMed]
  • So K, Tamura G, Honda T, Homma N, Waki T, Togawa N, Nishizuka S, Motoyama T. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci. 2006;97:1155–1158. [PubMed]
  • Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ. Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells. Oncogene. 2002;21:1048–1061. [PubMed]
  • Soshnikova N, Duboule D. Epigenetic temporal control of mouse Hox genes in vivo. Science. 2009;324:1320–1323. [PubMed]
  • Steemers FJ, Chang W, Lee G, Barker DL, Shen R, Gunderson KL. Whole-genome genotyping with the single-base extension assay. Nat. Methods. 2006;3:31–33. [PubMed]
  • Stelnicki EJ, Komuves LG, Kwong AO, Holmes D, Klein P, Rozenfeld S, Lawrence HJ, Adzick NS, Harrison M, Largman C. HOX homeobox genes exhibit spatial and temporal changes in expression during human skin development. J. Invest. Dermatol. 1998;110:110–115. [PubMed]
  • Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919–926. [PubMed]
  • Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 2004;64:3871–3877. [PubMed]
  • Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. U.S.A. 2005;102:15545–15550. [PMC free article] [PubMed]
  • Suzuki T, Farrar JE, Yegnasubramanian S, Zahed M, Suzuki N, Arceci RJ. Stable knockdown of PASG enhances DNA demethylation but does not accelerate cellular senescence in TIG-7 human fibroblasts. Epigenetics. 2008;3:281–291. [PMC free article] [PubMed]
  • Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci. 2005;96:206–211. [PubMed]
  • Vogt M, Haggblom C, Yeargin J, Christiansen-Weber T, Haas M. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ. 1998;9:139–146. [PubMed]
  • Wagner W, Ho AD. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev. 2007;3:239–248. [PubMed]
  • Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp. Hematol. 2005;33:1402–1416. [PubMed]
  • Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD. Replicative senescence of mesenchymal stem cells – a continuous and organized process. PLoS ONE. 2008;5:e2213. [PMC free article] [PubMed]
  • Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, Benes V, Blake J, Huber FX, Eckstein V, Boukamp P, Ho AD. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS ONE. 2009;4:e5846. [PMC free article] [PubMed]
  • Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science. 1983;220:1055–1057. [PubMed]
  • Young JI, Smith JR. DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J. Biol. Chem. 2001;276:19610–19616. [PubMed]
  • Zeng X. Human embryonic stem cells: mechanisms to escape replicative senescence? Stem Cell Rev. 2007;3:270–279. [PubMed]
  • Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS, Glowacki J. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell. 2008;7:335–343. [PMC free article] [PubMed]
  • Zimmermann P, Boeuf S, Dickhut A, Boehmer S, Olek S, Richter W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum. 2008;58:2743–2753. [PubMed]

Articles from Wiley-Blackwell Online Open are provided here courtesy of Wiley-Blackwell, John Wiley & Sons

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • GEO DataSets
    GEO DataSets
    GEO DataSet links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...